145 related articles for article (PubMed ID: 18669807)
1. Use of a uniform treatment algorithm abolishes racial disparities in glycemic control.
Rhee MK; Ziemer DC; Caudle J; Kolm P; Phillips LS
Diabetes Educ; 2008; 34(4):655-63. PubMed ID: 18669807
[TBL] [Abstract][Full Text] [Related]
2. A Comparison of the Use and Quality of Antidiabetic Medication Regimens Between Non-Hispanic Black and White Adults With Uncontrolled Type 2 Diabetes in the US: NHANES 2003-2012.
Perez A; Elrod S; Sanchez J
Diabetes Educ; 2016 Apr; 42(2):234-42. PubMed ID: 26850044
[TBL] [Abstract][Full Text] [Related]
3. Medication adherence and racial differences in A1C control.
Adams AS; Trinacty CM; Zhang F; Kleinman K; Grant RW; Meigs JB; Soumerai SB; Ross-Degnan D
Diabetes Care; 2008 May; 31(5):916-21. PubMed ID: 18235050
[TBL] [Abstract][Full Text] [Related]
4. Diabetes care in black and white veterans in the southeastern U.S.
Twombly JG; Long Q; Zhu M; Wilson PW; Narayan KM; Fraser LA; Webber BC; Phillips LS
Diabetes Care; 2010 May; 33(5):958-63. PubMed ID: 20103548
[TBL] [Abstract][Full Text] [Related]
5. Glycemic control and health disparities in older ethnically diverse underserved adults with diabetes: five-year results from the Informatics for Diabetes Education and Telemedicine (IDEATel) study.
Weinstock RS; Teresi JA; Goland R; Izquierdo R; Palmas W; Eimicke JP; Ebner S; Shea S;
Diabetes Care; 2011 Feb; 34(2):274-9. PubMed ID: 21270184
[TBL] [Abstract][Full Text] [Related]
6. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.
Kennedy L; Herman WH; Strange P; Harris A;
Diabetes Care; 2006 Jan; 29(1):1-8. PubMed ID: 16373887
[TBL] [Abstract][Full Text] [Related]
7. Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes.
Lafata JE; Karter AJ; O'Connor PJ; Morris H; Schmittdiel JA; Ratliff S; Newton KM; Raebel MA; Pathak RD; Thomas A; Butler MG; Reynolds K; Waitzfelder B; Steiner JF
J Gen Intern Med; 2016 Feb; 31(2):188-195. PubMed ID: 26282954
[TBL] [Abstract][Full Text] [Related]
8. Revisiting Disparities in Quality of Care Among US Adults With Diabetes in the Era of Individualized Care, NHANES 2007-2010.
Laiteerapong N; Fairchild PC; Chou CH; Chin MH; Huang ES
Med Care; 2015 Jan; 53(1):25-31. PubMed ID: 25373405
[TBL] [Abstract][Full Text] [Related]
9. Use of a glucose algorithm to direct diabetes therapy improves A1C outcomes and defines an approach to assess provider behavior.
Miller CD; Ziemer DC; Kolm P; El-Kebbi IM; Cook CB; Gallina DL; Doyle JP; Barnes CS; Phillips LS
Diabetes Educ; 2006; 32(4):533-45. PubMed ID: 16873591
[TBL] [Abstract][Full Text] [Related]
10. Racial comparisons of health care and glycemic control for African American and white diabetic adults in an urban managed care organization.
Gary TL; McGuire M; McCauley J; Brancati FL
Dis Manag; 2004; 7(1):25-34. PubMed ID: 15035831
[TBL] [Abstract][Full Text] [Related]
11. Self-management behaviors, racial disparities, and glycemic control among adolescents with type 2 diabetes.
Rothman RL; Mulvaney S; Elasy TA; VanderWoude A; Gebretsadik T; Shintani A; Potter A; Russell WE; Schlundt D
Pediatrics; 2008 Apr; 121(4):e912-9. PubMed ID: 18381520
[TBL] [Abstract][Full Text] [Related]
12. Ethnic disparity in hemoglobin A1c levels among normoglycemic offspring of parents with type 2 diabetes mellitus.
Chapp-Jumbo E; Edeoga C; Wan J; Dagogo-Jack S;
Endocr Pract; 2012; 18(3):356-62. PubMed ID: 22138077
[TBL] [Abstract][Full Text] [Related]
13. Differences in the Use and Quality of Antidiabetic Therapies in Mexican American and Non-Hispanic Whites With Uncontrolled Type 2 Diabetes in the US: NHANES 2003-2012.
Perez A; Elrod S; Sanchez J
Diabetes Educ; 2015 Oct; 41(5):582-91. PubMed ID: 26175481
[TBL] [Abstract][Full Text] [Related]
14. Racial differences in glycemic control in a well-functioning older diabetic population: findings from the Health, Aging and Body Composition Study.
de Rekeneire N; Rooks RN; Simonsick EM; Shorr RI; Kuller LH; Schwartz AV; Harris TB;
Diabetes Care; 2003 Jul; 26(7):1986-92. PubMed ID: 12832300
[TBL] [Abstract][Full Text] [Related]
15. Characterization of factors affecting attainment of glycemic control in Asian Americans with diabetes in a culturally specific program.
Le H; Wong S; Iftikar T; Keenan H; King GL; Hsu WC
Diabetes Educ; 2013; 39(4):468-77. PubMed ID: 23771841
[TBL] [Abstract][Full Text] [Related]
16. Reducing racial/ethnic disparities in diabetes: the Coached Care (R2D2C2) project.
Kaplan SH; Billimek J; Sorkin DH; Ngo-Metzger Q; Greenfield S
J Gen Intern Med; 2013 Oct; 28(10):1340-9. PubMed ID: 23645452
[TBL] [Abstract][Full Text] [Related]
17. Race in Older but Not Younger Patients Associated With Greater Glycemic Burden in Primary Care Patients.
Tucker JL; Zoberi KA; Hooks-Anderson DR; Salas J; Scherrer JF
Diabetes Educ; 2018 Dec; 44(6):549-557. PubMed ID: 30328788
[TBL] [Abstract][Full Text] [Related]
18. Rapid A1c availability improves clinical decision-making in an urban primary care clinic.
Miller CD; Barnes CS; Phillips LS; Ziemer DC; Gallina DL; Cook CB; Maryman SD; El-Kebbi IM
Diabetes Care; 2003 Apr; 26(4):1158-63. PubMed ID: 12663590
[TBL] [Abstract][Full Text] [Related]
19. Differences in Persistently Elevated Hemoglobin A1c for African American and White Patients and the Role of Provider-Level Variation.
Cunningham A; McAna J; Silverio A; Mills G; LaNoue M
Popul Health Manag; 2021 Aug; 24(4):478-481. PubMed ID: 33226887
[TBL] [Abstract][Full Text] [Related]
20. Impact of comorbid conditions and race/ethnicity on glycemic control among the US population with type 2 diabetes, 1988-1994 to 1999-2004.
Suh DC; Choi IS; Plauschinat C; Kwon J; Baron M
J Diabetes Complications; 2010; 24(6):382-91. PubMed ID: 19716320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
